Company profile: GRO Biosciences
1.1 - Company Overview
Company description
- Provider of protein therapeutics technology leveraging Genomically Recoded Organisms to produce non-standard amino acid proteins. Offers the GRO Platform to expand the amino acid alphabet; a Biofoundry integrating computational design and robotics; DuraLogic chemistry to enhance protein structure and duration; and ProGly to modulate immune responses, aiming to treat autoimmunity and reduce anti-drug antibodies.
Products and services
- Biofoundry: Architects an automation-driven system combining computational protein design with robotics to accelerate development of non-standard amino acid therapeutics
- DuraLogic: Creates a platform chemistry integrating non-standard amino acids to enhance protein structure and therapeutic duration of action for protein therapeutics
- GRO Platform: Engineers a genome-recoded system that expands the amino acid alphabet, using Genomically Recoded Organisms to produce non-standard amino acid proteins and enhance protein therapeutics
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to GRO Biosciences
Genial Genetics
HQ: United Kingdom
Website
- Description: Provider of health care equipment and services.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Genial Genetics company profile →
AutoCruitment
HQ: United States
Website
- Description: Provider of an automated digital patient recruitment platform for clinical trials, combining sophisticated algorithms, digital advertising, and automated screening to identify, pre-qualify, and refer patients in real time. Offers a secure site portal, EMR capture and AI-driven intelligence, targeted direct-to-patient outreach, and custom reports with live tracking.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full AutoCruitment company profile →
Immunetrics
HQ: United States
Website
- Description: Provider of biosimulation solutions for drug discovery and development, including Thales, a QSP model-building platform that automates and streamlines modeling, generates virtual patient populations, and refines designs; QSP modeling and consulting services; clinical trial simulations and optimization; non-inferiority/bioequivalence analysis; and trial power analysis to predict efficacy and optimize clinical trial design.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Immunetrics company profile →
Consensus
HQ: United States
Website
- Description: Provider of an AI-powered search engine that finds answers in scientific research, enabling discovery and consumption of the world's expert knowledge.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Consensus company profile →
Cellworks
HQ: United States
Website
- Description: Provider of life sciences technology for drug and bio-marker discovery and research in therapeutic areas.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Cellworks company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for GRO Biosciences
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to GRO Biosciences
2.2 - Growth funds investing in similar companies to GRO Biosciences
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for GRO Biosciences
4.2 - Public trading comparable groups for GRO Biosciences
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →